Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.

D-0789-2020

December 02, 2019

Class III

Product summary

Firm
AuroMedics Pharma LLC
Event
Event 84498
Status
Terminated
Classification
Class III
Quantity
100,080 bottles
Official record key
drug-enforcement:D-0789-2020

Official wording

Reason: Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.

Code information: Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.

Distribution pattern: Nationwide in the U.S.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.